[Second malignancies and cancer chemotherapy].
Horikoshi
N
N
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002699:Chlorambucil / Q000009:adverse effects; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000139:chemically induced; D008558:Melphalan / Q000009:adverse effects; D009369:Neoplasms / Q000188:drug therapy*; D012307:Risk Factors
D000970:Antineoplastic Agents; D002699:Chlorambucil; D008558:Melphalan